Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer
Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer
复制标题
DOI:
10.1016/j.ccell.2022.11.005
复制
发表时间:
2022-12-12
期刊:
影响因子:
50.3
通讯作者:
Liu, Zhuowei
中科院分区:
文献类型:
--
作者:
Ma, Zikun;Li, Xiangdong;Liu, Zhuowei
Cancer-associated fibroblasts (CAFs) play a role in response to cancer treatment and patient prognosis. CAFs show phenotypic and functional heterogeneity and differ widely in tumors of different tissue origin. Here, we use single-cell RNA sequencing of bladder cancer (BC) patient samples and report a CAF subpop-ulation characterized by overexpression of the urea transporter SLC14A1. This population is induced by inter-feron signaling and confers stemness to BC cells via the WNT5A paracrine pathway. Activation of cGAS-STING signaling in tumor cells drives interferon production, thereby revealing a link between cGAS-STING signaling and SLC14A1(+) CAF differentiation. Furthermore, the inhibition of SLC14A1(+) CAF formation via tar-geting of STAT1 or STING sensitizes tumor cells to chemotherapy. More important, BC patients with high pro-portions of intratumoral SLC14A1(+) CAFs show cancer stage-independent poor outcome and a worse response rate to neoadjuvant chemotherapy or immunotherapy.